Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 1, 2011, Pages 319-324

  Smith, Melissa E ^a   Cimica, Velasco ^a   Chinni, Srinivasa ^a   Jana, Suman ^a   Koba, Wade ^a   Yang, Zhixia ^a   Fine, Eugene ^a   Zagzag, David ^b   Montagna, Cristina ^a   Kalpana, Ganjam V ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Atypical teratoid rhabdoid tumors; Genetically engineered mouse model; hSNF5; SMARCB1

Indexed keywords

CYCLIN D1; FLAVOPIRIDOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; DRUG EFFECT; DRUG TARGETING; FEMALE; INI1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTOLOGICAL TECHNIQUES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LONGITUDINAL STUDIES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; PIPERIDINES; POLYMERASE CHAIN REACTION; POSITRON-EMISSION TOMOGRAPHY; RHABDOID TUMOR;

MUS;

EID: 78651106536     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913297108     Document Type: Article

References (21)

1. Biegel JA (2006) Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 20:E11.
2. Tekautz TM, et al. (2005) Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491-1499.
3. Versteege I, et al. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206.
4. Sévenet N, et al. (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65:1342-1348.
5. Chai J, Charboneau AL, Betz BL, Weissman BE (2005) Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 65:10192-10198.
6. Zhang ZK, et al. (2002) Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol 22:5975-5988.
7. Tsikitis M, Zhang Z, Edelman W, Zagzag D, Kalpana GV (2005) Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proc Natl Acad Sci USA 102:12129-12134.
8. Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J (2005) Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation. J Neurooncol 73:117-124.
9. McKenna ES, et al. (2008) Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 28:6223-6233.
10. Alarcon-Vargas D, et al. (2006) Targeting cyclin D1, a downstream effector of INI1/ hSNF5, in rhabdoid tumors. Oncogene 25:722-734.
11. Smith ME, et al. (2008) Rhabdoid tumor growth is inhibited by flavopiridol. Clin Cancer Res 14:523-532.
12. Sharpless NE, Depinho RA (2006) The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5:741-754.
13. Packer RJ, et al. (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 24:337-342.
14. 18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 7:369-379.
15. Loda M, Xu X, Pession A, Vortmeyer A, Giangaspero F (2000) Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system. Neuropathol Appl Neurobiol 26:91-97.
16. Hulsebos TJ, et al. (2007) Germlinemutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805-810.
17. Modena P, et al. (2005) SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65:4012-4019.
18. Swensen JJ, et al. (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68-72.
19. Bambakidis NC, Robinson S, Cohen M, Cohen AR (2002) Atypical teratoid/rhabdoid tumors of the central nervous system: Clinical, radiographic and pathologic features. Pediatr Neurosurg 37:64-70.
20. Cheng SW, et al. (1999) c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 22:102-105.
21. Montagna C, et al. (2003) The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 63:2179-2187.